BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay.

Abstract

BCR-ABL1 kinase domain mutations were evaluated in 60 imatinib-resistant patients with Philadelphia-positive (Ph(+)) leukemia using PCR-Invader assay and direct sequencing. In chronic myelogenous leukemia (CML)--chronic phase (CP), 5 had P-loop mutations and 3 had T315I mutations. CML-CP patients with high Sokal score showed significantly higher incidence… (More)

DOI: 10.1016/j.leukres.2010.12.006

Topics

4 Figures and Tables

Cited By

Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy

Masayuki Shiseki, Chikashi Yoshida, +12 authors Koiti Inokuchi
International Journal of Clinical Oncology
2017

Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.

Koichi Miyamura, Toshihiro Miyamoto, +20 authors Masafumi Taniwaki
Leukemia research
2016

Molecular response to nilotinib in a patient with imatinib-intolerant e19a2-positive chronic myeloid leukemia.

Tomohiro Kajiguchi, Shingo Okuno, Toshihito Ohno, Akihiro Abe
Internal medicine
2014

Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Daria A. Gaykalova, Elizabeth Mambo, +16 authors Wenyue Sun
PloS one
2014

Chronic myeloid leukemia

Leucemia mieloide crônica, Cármino Antonio de Souza, +5 authors Vaneuza Araújo
2013

Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012

Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano, +5 authors Wanderley Marques Bernardo
Revista brasileira de hematologia e hemoterapia
2012

References

Showing 1-8 of 8 references

Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction.

J G Hall, P S Eis, +10 authors V I Lyamichev
Proceedings of the National Academy of Sciences…
2000

Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.

Timothy Hughes, Giuseppe Saglio, +14 authors Andreas Hochhaus
Journal of clinical oncology : official journal…
2009

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Simona Soverini, Giovanni Martinelli, +17 authors Michele Baccarani
Journal of clinical oncology : official journal…
2005

Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients.

Sandrine Hayette, Mauricette Michallet, Marie-Laurence Baille, Jean-Pierre Magaud, Franck E Nicolini
Leukemia research
2005

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.

Susan Branford, Zbigniew Rudzki, +10 authors Tim Hughes
Blood
2003

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Jane F Apperley
The Lancet. Oncology
2007

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Brian J Druker, François Guilhot, +29 authors Richard A Larson
The New England journal of medicine
2006

A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia.

Catherine Roche-Lestienne, Jean-Luc Laï, Stéphane Darré, Thierry Facon, Claude Preudhomme
The New England journal of medicine
2003

Slides referencing similar topics

Cytogenetic Criteria: Philadelphia Chromosome
Katherine Walsh • Oct 25, 2017
Somatic translocations in cancer: Bcr-Abl leukemia
Aug 14, 2017
Antifungal therapy in leukemia patients
Raoul Herbrecht + 5 • Aug 27, 2017
Show More